Onyx Biotec Limited (NSE:ONYX)
India flag India · Delayed Price · Currency is INR
41.50
-0.50 (-1.19%)
At close: Oct 8, 2025

Onyx Biotec Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
619.51537.49394.82448.61
Other Revenue
--0.1-
619.51537.49394.92448.61
Revenue Growth (YoY)
15.26%36.10%-11.97%-
Cost of Revenue
400.97367.28221.33279.1
Gross Profit
218.55170.21173.59169.51
Selling, General & Admin
86.6359.57105.0386.56
Other Operating Expenses
28.2126.9623.125.69
Operating Expenses
145.32105.21143.05126.72
Operating Income
73.2365.0130.5442.79
Interest Expense
-19.93-21.07-5.65-5.15
Interest & Investment Income
1.730.750.650.1
Currency Exchange Gain (Loss)
---0.01-0
Other Non Operating Income (Expenses)
0.210.210.010.26
EBT Excluding Unusual Items
55.2444.925.5438
Gain (Loss) on Sale of Assets
9.54--0.07-0.05
Pretax Income
64.7844.925.4737.95
Income Tax Expense
15.248.557.024.42
Net Income
49.5436.3518.4533.53
Net Income to Common
49.5436.3518.4533.53
Net Income Growth
36.31%97.04%-44.98%-
Shares Outstanding (Basic)
15121212
Shares Outstanding (Diluted)
15121212
Shares Change (YoY)
25.51%1.13%--
EPS (Basic)
3.313.051.562.84
EPS (Diluted)
3.313.051.562.84
EPS Growth
8.60%95.20%-45.07%-
Free Cash Flow
3.62-17.07-165.01-53
Free Cash Flow Per Share
0.24-1.43-13.98-4.49
Gross Margin
35.28%31.67%43.95%37.79%
Operating Margin
11.82%12.09%7.73%9.54%
Profit Margin
8.00%6.76%4.67%7.47%
Free Cash Flow Margin
0.58%-3.17%-41.78%-11.82%
EBITDA
103.783.6845.4557.27
EBITDA Margin
16.74%15.57%11.51%12.77%
D&A For EBITDA
30.4718.6714.9114.48
EBIT
73.2365.0130.5442.79
EBIT Margin
11.82%12.09%7.73%9.54%
Effective Tax Rate
23.52%19.05%27.57%11.66%
Revenue as Reported
631.19538.74396.17449.81
Advertising Expenses
0.060.060.090.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.